Synapse - Brian Kushner

Results (311)

Naxitamab, a new generation anti-GD2 monoclonal antibody (mAb) for treatment of relapsed/refractory high-risk neuroblastoma (HR-NB)

Meeting Abstract

Mora, J.; Chan, G. C. F.; Morgenstern, D. A.; Nysom, K.; Bear, M. K.; Dalby, L. W.; Lisby, S.; Kushner, B. H.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma

Journal Article

Luo, L. Y.; Kramer, K.; Cheung, N. K. V.; Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Wolden, S. L.
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save

Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience

Journal Article

Patel, A.; Fischer, C.; Lin, Y. C.; Basu, E. M.; Kushner, B. H.; De Braganca, K.; Khakoo, Y.
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save

Focal nodular hyperplasia in survivors of childhood cancer

Meeting Abstract

Considine, C.; Do, K. G.; Moskowitz, C.; Tonorezos, E.; Behr, G.; Diotallevi, D.; Candela, J.; Kushner, B.; Wexler, L.; Boulad, F.; more...
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save

MYCN-amplified neuroblastoma with vasoactive intestinal peptide syndrome and BRAF V600e mutation

Meeting Abstract

Shahid, S.; Kushner, B.; Modak, S.; Basu, E.; Rubin, E.; Roberts, S.
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save

High-dose naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for high-risk neuroblastoma: Efficacy against histologically-evident primary refractory metastases in bone marrow

Meeting Abstract

Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Cheung, N. K.
Pediatric Blood and Cancer (2019)

Fulltext@MSK | Save

High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial

Meeting Abstract

Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
Pediatric Blood and Cancer (2019)

Fulltext@MSK | Save

High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial

Meeting Abstract

Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
Pediatric Blood and Cancer (2019)

Fulltext@MSK | Save

High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma

Meeting Abstract

Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
Pediatric Blood and Cancer (2019)

Fulltext@MSK | Save

Clinical impact of ALK mutations in neuroblastoma

Meeting Abstract

O'Donohue, T.; Gulati, N.; Shukla, N.; Roberts, S.; Basu, E.; Kushner, B.; Cheung, N. K.; Modak, S.
Pediatric Blood and Cancer (2019)

Fulltext@MSK | Save